Download presentation
Presentation is loading. Please wait.
1
Covering the Bases in Cardioversion
2
Program Goals and Talking Points
3
Patient Case : Scenario 1
4
Patient Case: Scenario 2
5
Cardioversion and the Risk for Stroke
6
Asymptomatic Episodes
7
Endocardial Remodeling
8
Symptomatic vs Asymptomatic AF
9
REVEAL AF: AF Incidence by CHADS2 Subgroup
10
Selecting an Anticoagulant: Convenience Counts
11
Persistence of Anticoagulants Following AF
12
NOAC Dosing
13
Other factors to Consider
14
ENSURE-AF Study Design
15
ENSURE-AF: Event Rates
16
Advantages of Using NOACs During Cardioversion
17
ENSURE-AF: Event Rates By Age and Gender
18
Stroke Risk vs Bleeding Risk
19
Short Duration of AF May confer risk
20
Abbreviations
21
Abbreviations (cont)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.